AndrewSaxonMD
Allergy & Immunology • Los Angeles, CAExecutive Director, Food and Drug Allergy Care Center; Physician, Clinical Immunology and Allergy; Professor Emeritus, Medicine; Clinical Immunology and Allergy, UCLA School of Medicine
Dr. Saxon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
UCLA Medical Ctr
10833 LeConte Ave
Los Angeles, CA 90095Phone+1 310-367-9736
Education & Training
Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1972 - 1975
Harvard Medical SchoolClass of 1972
Certifications & Licensure
CA State Medical License 1973 - 2026- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Diagnostic Laboratory Immunology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- Onsite Versus Referral Models of Primary Care for Substance Abusing Patients
- Prazosin Alcohol Dependence IVR Study Start of enrollment: 2005 Sep 01
- Starting Treatment With Agonist Replacement Therapies (START) Start of enrollment: 2006 Apr 01
Publications & Presentations
PubMed
- 3 citationsElevated customary alcohol consumption attenuates opioid effects.Monique M. Cherrier, Danny D. Shen, Laura M. Shireman, Andrew J. Saxon, Tracy L. Simpson
Pharmacology, Biochemistry, and Behavior. 2021-11-04 - 15 citationsReceipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems.Sarah M. Bagley, Laura J. Chavez, Jordan M. Braciszewski, Mary Akolsile, Denise M. Boudreau
Addiction Science & Clinical Practice. 2021-07-07 - 74 citationsHigh-Dose Buprenorphine Induction in the Emergency Department for Treatment of Opioid Use Disorder.Andrew A. Herring, Aidan A. Vosooghi, Joshua Luftig, Erik Anderson, Xiwen Zhao
JAMA Network Open. 2021-07-01
Grant Support
- Therapeutic And Anti-Inflammatory Effects Of Phase II "Anti-Oxidant" InductionNational Institute Of Allergy And Infectious Diseases2007–2008
- Allergy Therapy With Chimeric Human IG ProteinsNational Institute Of Allergy And Infectious Diseases2003–2007
- Therapeutic Anti-Inflammatory Phase II "Anti-Oxidant"National Institute Of Allergy And Infectious Diseases2006
- Clinical And Fundamental ImmunologyNational Institute Of Allergy And Infectious Diseases1990–2006
- Xenobiotics And Allergic InflammationNational Institute Of Allergy And Infectious Diseases2001–2005
- Blocking Xenobiotic And Allergen InflammationNational Institute Of Allergy And Infectious Diseases2001–2002
- Regulation Of IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1994–2002
- Xenobiotics And Allergic InflammationNational Institute Of Allergy And Infectious Diseases1997–2000
- Modulation Of The Human IGE Response By XenobioticsNational Institute Of Allergy And Infectious Diseases1997–2000
- Chimeric MRNA Templates Drive AIDS B Cell LymphomasNational Cancer Institute1998–1999
- Regulation Of B Cell Differentiation In Common Variable Immunodeficiency--Cd40National Cancer Institute1994–1998
- Regulation Of IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1997
- Core--Scid-Hu Mouse/Human Chimera Core FacilityNational Institute Of Allergy And Infectious Diseases1994–1997
- Molecular Regulation Of Allergic Immune InflammationNational Institute Of Allergy And Infectious Diseases1996
- Venoglobulin R-S Safety And Efficacy In Primary Immune DeficienciesNational Center For Research Resources1996
- Modulation Of The Human IGE Response By Polycyclic Aromatic HydrocarbonsNational Institute Of Allergy And Infectious Diseases1994–1996
- Molecular Regulation Of Allergic-Immune InflammationNational Institute Of Allergy And Infectious Diseases1993–1996
- Venoglobulin R-S Safety And Efficacy In Subjects With Primary Immune DeficienciesNational Center For Research Resources1995
- IrradiatorNational Center For Research Resources1995
- Regulation Of Human IGE In Health And DiseaseNational Institute Of Allergy And Infectious Diseases1985–1993
- Triatoma Protracta HypersensitivityNational Institute Of Allergy And Infectious Diseases1985
- Therapy In Immunodeficiency SymdromesNational Center For Research Resources1985
- L.V. Infusion Of Modified Serum Immunoglobulin--Immunodeficiency SyndromeNational Center For Research Resources1985
- Immune Reconstitution Following B.M. TransplantationNational Cancer Institute1985
- Control Of The Human B Cell Response By Genomic MechanismsNational Cancer Institute1985
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
